|
1.
|
|
|
2.
|
|
28 p, 397.3 KB |
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
/
Lam, Thomas B.L. (Aberdeen Royal Infirmary) ;
MacLennan, Steven (University of Aberdeen) ;
Willemse, Peter-Paul M. (University Medical Center Utrecht) ;
Mason, Malcolm D. (Velindre Cancer Centre) ;
Plass, Karin (EAU Guidelines Office) ;
Shepherd, Robert (EAU Guidelines Office) ;
Baanders, Ruud ;
Bangma, Chris H. (Erasmus University Medical Centre) ;
Bjartell, Anders (Lund University) ;
Bossi, Alberto (Gustave Roussy Institute) ;
Briers, Erik ;
Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ;
Buddingh, Karel T. (HagaZiekenhuis) ;
Catto, James W.F. (Royal Hallamshire Hospital) ;
Colecchia, Maurizio (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ;
Cox, Brett W. (Zucker School of Medicine) ;
Cumberbatch, Marcus G. (University of Sheffield) ;
Davies, Jeff ;
Davis, Niall F. (Royal College of Surgeons in Ireland) ;
De Santis, Maria (Charité University Hospital) ;
Dell'Oglio, Paolo (ORSI Academy) ;
Deschamps, André (Europa Uomo) ;
Donaldson, James F. (Aberdeen Royal Infirmary) ;
Egawa, Shin (Jikei University School of Medicine) ;
Fankhauser, Christian D. (University of Zurich) ;
Fanti, Stefano (University of Bologna) ;
Fossati, Nicola (Scientific Institute and University Vita-Salute San Raffaele Hospital) ;
Gandaglia, Giorgio (IRCCS Ospedale San Raffaele) ;
Gillessen, Silke (University of Bern) ;
Grivas, Nikolaos (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Gross, Tobias (University of Bern) ;
Grummet, Jeremy P. (Monash University) ;
Henry, Ann M. (St. James's University Hospital) ;
Ingels, Alexandre (Henri Mondor Hospital) ;
Irani, Jacques (University Hospital of Bicêtre-Paris Sud-Saclay University) ;
Lardas, Michael (Department of Reconstructive Urology and Surgical Andrology) ;
Liew, Matthew (Wigan and Leigh NHS Foundation Trust) ;
Lin, Daniel W. (University of Washington) ;
Moris, Lisa (KU Leuven) ;
Omar, Muhammad Imran (University of Aberdeen) ;
Pang, Karl H. (University of Sheffield) ;
Paterson, Catherine C. (Robert Gordon University) ;
Renard-Penna, Raphaële (Sorbonne Université) ;
Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ;
Roobol, M.J. (Erasmus University Medical Centre) ;
Rouprêt, Morgan (Sorbonne Université) ;
Rouvière, Olivier (Université de Lyon) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Richenberg, Jonathan (Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School) ;
Schoots, Ivo G. (Erasmus University Medical Center) ;
Sedelaar, J.P.Michiel (Radboud University Medical Centre) ;
Stricker, Phillip (Garvan Institute of Research) ;
Tilki, Derya (University Hospital Hamburg-Eppendorf) ;
Vahr Lauridsen, Susanne (Copenhagen University Hospital) ;
van den Bergh, Roderick C.N. (St. Antonius Hospital) ;
Van den Broeck, Thomas (University Hospitals Leuven (Bèlgica)) ;
van der Kwast, Theodorus H. (Erasmus University Medical Center) ;
van der Poel, Henk G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van Leenders, Geert J.L.H. (Erasmus University Medical Center) ;
Varma, Murali (University Hospital of Wales) ;
Violette, Philippe D. (McMaster University (Canadà)) ;
Wallis, Christopher J.D. (Vanderbilt University Medical Center) ;
Wiegel, Thomas (University Hospital of Ulm (Alemanya)) ;
Wilkinson, Karen (University College London Hospitals) ;
Zattoni, Fabio (Academic Medical Centre Hospital) ;
N'Dow, James M.O. (Aberdeen Royal Infirmary) ;
Van Poppel, Hendrik (University Hospitals Leuven (Bèlgica)) ;
Cornford, Philip (Royal Liverpool and Broadgreen Hospitals NHS Trust) ;
Mottet, Nicolas (University Hospital Jean Monnet) ;
Universitat Autònoma de Barcelona
There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. To develop consensus statements for all domains of DAT. [...]
2019 -  10.1016/j.eururo.2019.09.020
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 790-813
|
|
|
3.
|
|
14 p, 695.4 KB |
Comparative effectiveness of biologics in clinical practice : week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)
/
Pinter, Andreas (University Hospital of Frankfurt (Alemanya)) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Schäkel, Knut (Heidelberg University Hospital (Alemanya)) ;
Reich, Adam (Institute of Medical Sciences. Medical College of Rzeszow University) ;
Zaheri, Shirin (Imperial College Healthcare NHS Trust) ;
Costanzo, Antonio (Humanitas Research Hospital Pieve Emanuele (Milà, Itàlia)) ;
Tsai, Tsen-Fang (National Taiwan University Hospital and National Taiwan University College of Medicine) ;
Smith, Saxon Donald (Australian National University,College of Health and Medicine) ;
Lynde, Charles W. (University of Toronto) ;
Brnabic, Alan (Eli Lilly and Company) ;
Reed, Catherine L. (Eli Lilly and Company) ;
Hill, Julie (Eli Lilly and Company) ;
Schuster, Christopher F. (Medical University of Vienna) ;
Riedl, Elisabeth (Medical University of Vienna) ;
Paul, Carle (Paul Sabatier University and Larrey Hospital (Toulose, França)) ;
Universitat Autònoma de Barcelona
Background: Clinical trials study treatment outcomes under stringent conditions, capturing incompletely the heterogeneity of patient populations and treatment complexities encountered in real-world practice. [...]
2022 - 10.1111/jdv.18376
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 11 (november 2022) , p. 2087-2100
|
|
|
4.
|
|
16 p, 656.7 KB |
Athletes with eating disorders : analysis of their clinical characteristics, psychopathology and response to treatment
/
Ibáñez-Caparrós, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Sánchez, Isabel (Hospital Universitari de Bellvitge) ;
Granero, Roser (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ;
Jiménez-Murcia, Susana (Hospital Universitari de Bellvitge) ;
Rosinska, Magda (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Thiel, Ansgar (University of Tübingen, Germany) ;
Zipfel, Stephan (University of Tübingen, Germany) ;
de Pablo, Joan (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Camacho-Barcia, Lucía (Hospital Universitari de Bellvitge) ;
Fernández-Aranda, Fernando (Hospital Universitari de Bellvitge) ;
Universitat Autònoma de Barcelona
Eating disorders (ED) have frequently been described among athletes. However, their specific features and therapy responses are lacking in the literature. The aims of this article were to compare clinical, psychopathological and personality traits between ED patients who were professional athletes (ED-A) with those who were not (ED-NA) and to explore differences in response to treatment. [...]
2023 - 10.3390/nu15133003
Nutrients, Vol. 15 (june 2023)
|
|
|
5.
|
|
8 p, 708.2 KB |
Automated scoring of collaterals, blood pressure, and clinical outcome after endovascular treatment in patients with acute ischemic stroke and large-vessel occlusion
/
Guisado-Alonso, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Camps-Renom, Pol (Institut d'Investigació Biomèdica Sant Pau) ;
Delgado Mederos, Raquel (Institut d'Investigació Biomèdica Sant Pau) ;
Granell, Esther (Unitat de Diagnòstic per la Imatge d'Alta Tecnologia) ;
Prats-Sánchez, Luis Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Martínez-Domeño, Alejandro (Institut d'Investigació Biomèdica Sant Pau) ;
Guasch-Jiménez, Marina (Institut d'Investigació Biomèdica Sant Pau) ;
costa, M. Victoria (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Ramos-Pachón, Anna (Institut d'Investigació Biomèdica Sant Pau) ;
Martí-Fàbregas, Joan (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Introduction: We aimed to determine whether the degree of collateral circulation is associated with blood pressure at admission in acute ischemic stroke patients treated with endovascular treatment and to determine its prognostic value. [...]
2022 - 10.3389/fneur.2022.944779
Frontiers in neurology, Vol. 13 (september 2022) , p. 944779
|
|
|
6.
|
|
13 p, 1.5 MB |
Are there clinical, psychopathological and therapy outcomes correlates associated with self-exclusion from gambling?
/
Uríszar, Juan C. (Hospital Universitari de Bellvitge) ;
Gaspar-Pérez, Anahí (Hospital Universitari de Bellvitge) ;
Granero, Roser (Hospital Universitari de Bellvitge) ;
Munguía, Lucero (Hospital Universitari de Bellvitge) ;
Lara-Huallipe, Milagros Lizbeth (Hospital Universitari de Bellvitge) ;
Mora-Maltas, Bernat (Hospital Universitari de Bellvitge) ;
Baenas Soto, Isabel Maria (Hospital Universitari de Bellvitge) ;
Etxandi, Mikel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gomez-Peña, Mónica (Hospital Universitari de Bellvitge) ;
Moragas, Laura (Hospital Universitari de Bellvitge) ;
Sisquellas, Claudia (Hospital Universitari de Bellvitge) ;
Fernández-Aranda, Fernando (Hospital Universitari de Bellvitge) ;
Jiménez-Murcia, Susana (Hospital Universitari de Bellvitge) ;
Universitat Autònoma de Barcelona
Self-exclusion in gambling disorder (GD) is considered a measure to decrease the negative consequences of gambling behavior. Under a formal self-exclusion program, gamblers request to be banned from accessing to the gambling venues or online gambling. [...]
2023 - 10.1556/2006.2023.00018
Journal of behavioral addictions, Vol. 12 (may 2023) , p. 522-534
|
|
|
7.
|
|
9 p, 690.9 KB |
Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children Efectividad y seguridad de los bisfosfonatos en el tratamiento de la osteoporosis infantil secundaria
/
Galindo Zavala, Rocío (Hospital Materno-Infantil de Málaga. Unidad de Pediatría, Sección Reumatología Pediátrica) ;
Bou, Rosa (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Mir-Perelló, Concepción (Institut d'Investigació Sanitària Illes Balears) ;
Martínez Regueira, Soledad (Complejo Hospitalario Universitario de A Coruña) ;
Magallares López, Berta Paula (Institut d'Investigació Biomèdica Sant Pau) ;
López-Corbeto, Mireia (Hospital Universitari Vall d'Hebron)
Introduction: There are few studies on effectiveness and safety of bisphosphonate therapy in secondary osteoporosis in children. The aim of this research was to analyse effectiveness and safety of bisphosphonates in secondary osteoporosis in children. [...]
2022 - 10.1016/j.anpedi.2021.09.008
Anales de pediatría, Vol. 97 Núm. 3 (septiembre 2022) , p. 190-198
|
|
|
8.
|
|
15 p, 669.1 KB |
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19
/
Collazos, Julio (Hospital de Galdakao. Servicio de Enfermedades Infecciosas) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Fernández-Araujo, Nerio (Hospital General Universitario Gregorio Marañón) ;
Asensi-Díaz, Elia (Hospital Universitario Fundación Jiménez Díaz) ;
Vilchez-Rueda, Helem (Hospital Universitario Son Espases. Enfermedades Infecciosas) ;
Lalueza, Antonio (Hospital Universitario 12 de Octubre (Madrid)) ;
Roy-Vallejo, Emilia (Hospital Universitario de La Princesa. Enfermedades Infecciosas) ;
Blanes, Rosa (Hospital Universitari i Politècnic La Fe (València)) ;
Raya-Cruz, Manuel (Hospital Son Llàtzer. Servicio de Medicina Interna) ;
Sanz-Cánovas, Jaime (Hospital Regional Universitario de Málaga) ;
Artero, Arturo (Hospital Universitari Doctor Peset (València)) ;
Ramos-Rincón, José-Manuel (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Dueñas-Gutiérrez, Carlos (Hospital Clínico Universitario de Valladolid. Unidad de Enfermedades Infecciosas) ;
Lamas-Ferreiro, José Luis (Hospital Ribera POVISA. Servicio de Medicina Interna) ;
Asensi, Víctor (Hospital Universitario Central de Asturias. Unidad de Enfermedades Infecciosas)
Background Valproic acid (VPA) has shown beneficial effects in vitro against SARS-CoV-2 infection, but no study has analyzed its efficacy in the clinical setting. Methods This multicenter, retrospective study included 165 adult patients receiving VPA at the time of admission to hospital, and 330 controls matched for sex, age and date of admission. [...]
2022 - 10.1371/journal.pone.0262777
PloS one, Vol. 17 Núm. 1 January (january 2022) , p. e0262777
|
|
|
9.
|
|
11 p, 473.7 KB |
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting : PROTEC
/
Berger, Thomas (Universitätsklinik für Neurologie) ;
Brochet, B. (Groupe Hospitalier Pellegrin Hôpital Pellegrin) ;
Brambilla, L. (IRCCS Foundation Neurological Institute Carlo Besta) ;
Giacomini, P.S. (Montreal Neurological Institute Hospital) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Vasco Salgado, A (Hospital Professor Doutor Fernando Fonseca) ;
Su, R (Biogen, USA) ;
Bretagne, A (Biogen International GmbH) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Background: Patient-reported outcomes (PRO) and clinical outcomes give a broad assessment of relapsing-remitting multiple sclerosis (RRMS) disease. Objective: The aim is to evaluate the effectiveness of delayed-release dimethyl fumarate (DMF) on disease activity and PROs in patients with RRMS in the clinic. [...]
2019 - 10.1177/2055217319887191
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 5 Núm. 4 (2019)
|
|
|
10.
|
|
8 p, 1.1 MB |
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis : Benefit/risk following review of trial and post-marketing data
/
Coles, Alasdair J. (University of Cambridge) ;
Jones, Joanne L. (University of Cambridge) ;
Vermersch, Patrick (Université de Lille) ;
Traboulsee, Anthony (University of British Columbia) ;
Bass, Ann D. (Neurology Center of San Antonio) ;
Boster, Aaron (Boster Center for Multiple Sclerosis) ;
Chan, Andrew (University of Bern) ;
Comi, Giancarlo (Vita-Salute San Raffaele University) ;
Fernández, Óscar (Hospital Regional Universitario Carlos Haya (Málaga)) ;
Giovannoni, Gavin (Queen Mary University of London) ;
Kubala Havrdova, Eva (Charles University) ;
LaGanke, Christopher (North Central Neurology Associates) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Oreja-Guevara, Celia (Universidad Complutense de Madrid) ;
Piehl, Fredrik (Karolinska Institutet (Estocolm, Suècia)) ;
Wiendl, Heinz (University of Münster) ;
Ziemssen, Tjalf (Dresden University of Technology) ;
Universitat Autònoma de Barcelona
Does preexisting or treatment-emergent autoimmunity increase the risk of subsequent autoimmune disease in individuals with relapsing-remitting multiple sclerosis (MS) after alemtuzumab? In the extended phase 2/3 trials, 34/96 (35. [...]
2022 - 10.1177/13524585211061335
Multiple sclerosis, Vol. 28 Núm. 5 (2022) , p. 842-846
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
